Multi-parametric assessment of cardiomyocyte excitation-contraction coupling using impedance and field potential recording: A tool for cardiac safety assessment
Authors:
- 1 September 2016
- journal article
- Published by Elsevier in Journal of Pharmacological and Toxicological Methods
- Vol. 81, 201-216
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health (HHSN261200800001E)
- Developmental Therapeutics Program
This publication has 37 references indexed in Scilit:
- Evolution of strategies to improve preclinical cardiac safety testingNature Reviews Drug Discovery, 2016
- A New Perspective in the Field of Cardiac Safety Testing through the Comprehensive In Vitro Proarrhythmia Assay ParadigmSLAS Discovery, 2016
- Inhibition of hERG potassium channel by the antiarrhythmic agent mexiletine and its metabolite m‐hydroxymexiletinePharmacology Research & Perspectives, 2015
- Incorporating exposure-response modeling into the assessment of QTc interval: A potential alternative to the thorough QT study.Clinical Pharmacology & Therapeutics, 2015
- Dynamic monitoring of beating periodicity of stem cell‐derived cardiomyocytes as a predictive tool for preclinical safety assessmentBritish Journal of Pharmacology, 2011
- hERG channel trafficking: novel targets in drug-induced long QT syndromeBiochemical Society Transactions, 2007
- QT prolongation and proarrhythmia by moxifloxacin: concordance of preclinical models in relation to clinical outcomeBritish Journal of Pharmacology, 2005
- ICH S7B draft guideline on the non-clinical strategy for testing delayed cardiac repolarisation risk of drugs: a critical analysisExpert Opinion on Drug Safety, 2005
- Anti-ischemic effects and long-term survival during ranolazine monotherapy in patients with chronic severe anginaJACC, 2004
- Cardiac excitation–contraction couplingNature, 2002